Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy
- 30 September 2004
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 44 (3) , 455-465
- https://doi.org/10.1053/j.ajkd.2004.04.049
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Low, Rather than a High, Total Plasma Homocysteine Is an Indicator of Poor Outcome in Hemodialysis PatientsJournal of the American Society of Nephrology, 2004
- Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patientsKidney International, 2003
- Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patientsKidney International, 2002
- An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal diseaseKidney International, 2001
- Plasma reduced homocysteine concentrations are increased in end-stage renal diseaseKidney International, 2001
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patientsKidney International, 2000
- Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureKidney International, 1999
- Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysisKidney International, 1999
- Major determinants of hyperhomocysteinemia in peritoneal dialysis patientsKidney International, 1998
- Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patientsKidney International, 1996